News

Filter

Current filters:

Eli LillyProduction

Lilly to appeal $450 million fine in Brazil labor case

Lilly to appeal $450 million fine in Brazil labor case

10-05-2014

US drug major Eli Lilly revealed on Friday that the 2nd Circuit of the Labor Court of Paulinia in the…

BrazilEli LillyLegalPharmaceuticalProduction

Lilly and Novast to expand manufacturing facility in Nantong, China

Lilly and Novast to expand manufacturing facility in Nantong, China

06-03-2014

US pharma major Eli Lilly and China-based generic and specialty pharmaceutical company Novast Laboratories…

Asia-PacificChinaEli LillyNovast LaboratoriesPharmaceuticalProduction

FDA issues CRL on empagliflozin, noting manufacturing deficiencies

FDA issues CRL on empagliflozin, noting manufacturing deficiencies

05-03-2014

There was disappointment today for US drug major Eli Lilly and family-owned German pharma firm Boehringer…

Boehringer IngelheimDiabetesEli LillyempagliflozinNorth AmericaPharmaceuticalProductionRegulationUSA

Eli Lilly to expand manufacturing plants in Brazil’s growing pharma market

Eli Lilly to expand manufacturing plants in Brazil’s growing pharma market

03-03-2014

US pharma major Eli Lilly’s subsidiary in Brazil will invest 15 million real ($6.4 million) over the…

BrazilEli LillyPharmaceuticalPricingProductionSouth America

Eli Lilly to invest further $700 million to boost insulin production

Eli Lilly to invest further $700 million to boost insulin production

14-11-2013

US pharma major Eli Lilly plans to invest more than $700 million to enhance its global insulin manufacturing…

DiabetesEli LillyFinancialPharmaceuticalProductionResearch

Geropharm to invest $45 million in Russian insulin production

Geropharm to invest $45 million in Russian insulin production

25-09-2013

Geropharm, one of Russia’s leading pharmaceutical and biotech companies, is establishing a plant for…

DiabetesEli LillyEuropeFinancialGeropharmNovo NordiskPharmaceuticalProductionSanofi

AAA enters supply deal with Eli Lilly for Amyvid in France, Italy and Spain

24-05-2013

France-based molecular nuclear medicine firm Advanced Accelerator Applications (AAA) says it has signed…

Advanced Accelerator ApplicationsAmyvidEli LillyNeurologicalPharmaceuticalProduction

News briefs: Eli Lilly expands insulin facility; and Sanofi criticized over Lemtrada

02-11-2012

US drug major Eli Lilly (NYSE: LLY) has announced a $140 million expansion to the company's Indianapolis…

BiotechnologyDiabetesEli LillyLemtradaNeurologicalPharmaceuticalPricingProductionSanofi

COMPANY SPOTLIGHT

Menarini

Back to top